Molecular Health

Company Snapshot

Founded: 2004
Entity Type: Private
Region: Germany
Headquarter: Heidelberg, Germany
Key Geographics: Germany, U.S.
Corporate Address: Kurfuersten-Anlage 21, Heidelberg 69115 Germany Tel. +49-6221-43851-0 www.molecularhealth.com

Company Overview

Molecular Health GmbH, founded in 2004, develops software for clinical decisions support. The company maintained a laboratory in Houston but decommissioned it in 2016 to focus on software products. The company is commercializing the informatics products that were used at the lab and markets them under the Dataome name.

The lead products, Workbench Manager and Clinical Annotation Service, use Molecular’s Dataome cloud-based platform. Workbench Manager is aimed at smaller labs that need help in setting up their bioinformatics workflow. The product converts raw sequence files to final variant calls. It also uses curated content from Dataome for preparing reports to physicians who are treating patients.

The Clinical Annotation Service is aimed at higher-throughput laboratories. It interprets and annotates actional variants that are present in tumor samples. The service provides variant descriptions, treatment options, matching clinical trials and drug-drug interaction information to physicians.

Molecular Health In Reports

Global DNA Read, Write and Edit Market

The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate of 20.5% during the period of 2019-2024.

Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023

Get an overview of the global markets for liquid biopsy technologies, applications, industry subsegments along with analyses of global market trends with data from 2017, 2018 and projections of CAGRs through 2023 ...

Global DNA Sequencing: Research, Applied and Clinical Markets

The global DNA sequencing market was $10.7 billion in 2018 and is forecast to increase at a compound annual growth rate of 18.0% to reach $24.4 billion in 2023.

Company's Business Segments

  • Software Solutions : This segment includes providing Data Driven Software Solutions by leverging Unique Symbiosis of Human Expertise, State-of-the-Art Data Curation, Deep Analytics.

Applications/End User Industries

  • Software as a Service
  • Molecular Tumor Profiling
  • Variant Annotation and Reporting Solution
  • Tertiary Analysis
  • Bioinformatic Analysis
  • Data Curation
  • NGS Biomarkers
  • Pharma AI Solutions
AI Sentiment